Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05641194 · ClinicalTrials.gov registry record · NA
EaseAlert: Tactile Firefighter Alerting System
A NA study of Sleep and Heart Rate, sponsored by Embry-Riddle Aeronautical University.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
- 2
- Study locations
NCT05641194: Completed NA study of Sleep and Heart Rate, sponsored by Embry-Riddle Aeronautical University.
NCT05641194 is a NA study of Sleep and Heart Rate that has completed, run by Embry-Riddle Aeronautical University. The registered enrollment target is 47 participants, below the 4,166-participant average among 151 other Sleep trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05641194, a NA study of Sleep and Heart Rate, has completed, sponsored by Embry-Riddle Aeronautical University.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this research is to test a commercially viable Fire Fighter Altering System (FFAS) comprised of proprietary wearables and optional bed shakers called BunkAlerts; collectively "personal alerting devices" as an alternative approach to the traditional fire alarm system used in fire stations. Participants (fire fighters) will be asked to take part in the study to investigate the impact of the new FFAS on cardiovascular response and sleep. This study includes three phases: 1) baseline, 2) implementation of EaseAlert FFAS with traditional alarm, and 3) implementation of EaseAlert FFAS without traditional alarm. Participants will be asked to wear an Actigraph wGT3x-BT and Polar H10 device to record sleep and heart rate data for 12 days at work in addition to EaseAlert FFAS device for 8 out of the 12 days at work. They will also be asked to complete a questionnaire and complete daily journal entries.
Primary Outcome
Heart Rate will be measured with Polar H10 Heart Rate Chest Strap Monitor connected via Bluetooth to wGT3X-BT Actigraphy device. Change from baseline Heart Rate to post interventions
Conditions Studied
Interventions
- DEVICE Legacy Alerting System
- DEVICE Intervention 2: EaseAlert Standalone
Study Locations (2)
Missouri
- Central Jackson County Fire District - Blue Springs
Oklahoma
- Stillwater Fire Department - Stillwater
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2023-08-26 |
| Est. Completion | 2025-01-31 |
| Phase | NA |
What the finished NCT05641194 record still lists
NCT05641194 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 47 participants, a relatively small participant target, below the 4,166-participant average among 151 other Sleep trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with Sleep appearing as the primary indexed condition, and to 2 interventions - of which Legacy Alerting System is the first listed.
NCT05641194 reports a single indexed study location in Missouri, Oklahoma.
Frequently Asked Questions
What is clinical trial NCT05641194 about?
NCT05641194 is a clinical study titled "EaseAlert: Tactile Firefighter Alerting System". The purpose of this research is to test a commercially viable Fire Fighter Altering System (FFAS) comprised of proprietary wearables and optional bed shakers called BunkAlerts; collectively "personal alerting devices" as an alternative approach to the traditional fire alarm system used in fire stati...
What is the current status of trial NCT05641194?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2023-08-26. Estimated completion is 2025-01-31.
What conditions does trial NCT05641194 study?
This clinical trial studies the following conditions: Sleep, Heart Rate, Sleep Habit.
What interventions are being tested in trial NCT05641194?
The interventions under investigation include: Legacy Alerting System (DEVICE), Intervention 2: EaseAlert Standalone (DEVICE).
Who is sponsoring clinical trial NCT05641194?
This trial is sponsored by Embry-Riddle Aeronautical University, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05641194 being conducted?
This trial has 2 study locations across Missouri, Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05641194's enrollment target sits among peer trials
47 107th of 151 higher than 45 of 151 other Sleep trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sleep trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Student Exercise and Sleep Timing Study - Part 2
RECRUITING · NA
-
The Effects of Sleep on Human Microbiota: Implications for Health and Disease
RECRUITING · NA
-
The Goodnight Screen Media Study
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
Shifting Sleep Timing in Teens
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03313011 · 47 participants
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
- NCT03467516 · 47 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
- NCT03886662 · 47 participants · Phase 1
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- NCT04013802 · 47 participants · Phase 1
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI